Lower extremity cellulitis (1:30), Kawasaki disease (4:00), pelvic floor muscle training (8:20), parasitic infections (10:30), Helicobacter pylori infection treatment (16:50), and calprotectin in the evaluation of inflammatory bowel disease (19:50).
Human papillomavirus (1:40), state-level variation in primary care (5:30), dysmenorrhea (7:40), diverticulitis (11:00), physical activity to prevent depression (12:40), diabetes medications and cardiovascular outcomes (15:00).